| Literature DB >> 33403107 |
Catherine Clarence1, Tess Shiras1, Jack Zhu2, Malia K Boggs3, Nefra Faltas3, Anna Wadsworth1, Sarah Ek Bradley1, Salim Sadruddin4, Kerri Wazny5, Catherine Goodman6, Phyllis Awor7, Zulfiqar A Bhutta8,9, Karin Källander10,11, Davidson H Hamer2,12.
Abstract
BACKGROUND: The private health sector is an important source of sick child care, yet evidence gaps persist in best practices for integrated management of private sector child health services. Further, there is no prioritized research agenda to address these gaps. We used a Child Health and Nutrition Research Initiative (CHNRI) process to identify priority research questions in response to these evidence gaps. CHNRI is a consultative approach that entails prioritizing research questions by evaluating them against standardized criteria.Entities:
Mesh:
Year: 2020 PMID: 33403107 PMCID: PMC7750021 DOI: 10.7189/jogh.10.021201
Source DB: PubMed Journal: J Glob Health ISSN: 2047-2978 Impact factor: 4.413
Figure 1Distribution of CHNRI participants by geographic region. CHNRI − Child Health and Nutrition Research Initiative
Figure 2Distribution of CHNRI Participants. by type of institutional affiliation. CHNRI − Child Health and Nutrition Research Initiative.
Evaluation criteria for private sector CHNRI exercise
| Category | Evaluation criteria |
|---|---|
| 1. Can a single study or a very small number of studies be designed to answer the research question? | |
| 2. Does the research question have measurable outcome indicators? | |
| 3. Is it feasible to design and conduct a study in response to this research question? ( | |
| 4. Depending upon the outcome of the research study, could this research result in a | |
| 5. Are the results from this research likely to result in a | |
| 6. Are the results from this research likely to lead to an intervention or strategy that will strengthen partnerships between the private sector and government? | |
| 7. Will the results from this research lead to more equitable outcomes? | |
| 8. Will the results of this research fill an important knowledge gap? | |
| 9. Are the results from this research likely to inform future policy and practice? | |
| 10. Will the results from this research be relevant to at least one aspect of the private sector across a range of low-and middle-income countries (as opposed to one country)? | |
| 11. Will the results from the research help to strengthen quality of care provided by private health care providers (eg, clinicians, pharmacists, shop keepers)? |
Overall rank, evaluation criteria scores, research priority scores, and average expert agreement for top 15 research questions among all respondents
| Rank | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Research question | Does accreditation or regulation of private clinical and non-clinical sources of care improve IMCI diagnosis, treatment, and appropriateness of testing and prescription? | Can supportive supervision lead to improved quality of care in the private sector? | What is the effectiveness of training private sector medicine vendors (ie, private drug shops, pharmacists, chemists, patent medicine vendors, etc.) to recognize, manage and/or refer sick young infants | Can tools (eg, flipchart, decision tree, and other job aids) used by private providers/pharmacies/drug shops improve adherence to child health protocols (diarrhea and pneumonia management, malaria treatment, and nutritional screening and counseling? | What are the key drivers of appropriate and inappropriate antimalarial and antibiotic prescription for children in private-for-profit sources of care by type of provider? | How can the integration of routine child health data from private sector providers (clinical and non-clinical) into national health information systems be improved and sustained? | What are the referral pathways in the private sector and what factors contribute to appropriate referrals to or from private sector providers? | What models of supportive supervision for child health service delivery are most cost-effective in the private sector? | What interventions are most effective in closing the gap between private provider knowledge and implementation of IMCI protocols? | What factors contribute to private provider adherence to IMCI protocols? | Can the iCCM approach be used in private non-clinical sources of care at scale to provide quality, appropriate, affordable, and accessible care? | Can government medicine regulatory authorities improve the quality of antimalarial medicines and antibiotics distributed by private drug shops or their equivalent through the use of periodic audits with a portable device to assess drug quality? | What can be done to reduce over-prescription of antibiotics when malaria rapid diagnostic testing results are negative and there are no other indications for antibiotic use? | What factors contribute to the gap between private provider knowledge of IMCI protocols and their implementation of IMCI protocols? | How well do private sector providers adhere to IMCI protocols? |
| Answerability Question 1 Score: Single studies or small number of studies? | 77 | 81 | 79 | 81 | 79 | 74 | 76 | 74 | 72 | 80 | 73 | 80 | 75 | 77 | 78 |
| Answerability Question 2 Score: Measurable outcome indicators? | 85 | 86 | 86 | 87 | 82 | 79 | 78 | 80 | 80 | 83 | 79 | 83 | 76 | 81 | 84 |
| Research Feasibility Priority Score: Feasible to design and conduct study? | 81 | 85 | 81 | 85 | 84 | 80 | 81 | 78 | 80 | 83 | 79 | 82 | 77 | 79 | 86 |
| Sustainability and Equity Question 1 Score: Results in sustainable intervention/ strategy to implement within context of private sector? | 84 | 83 | 81 | 83 | 81 | 82 | 79 | 81 | 82 | 80 | 78 | 78 | 78 | 78 | 70 |
| Sustainability and Equity Question 2 Score: Results in scalable intervention/ strategy to implement within context of private sector? | 86 | 79 | 78 | 83 | 79 | 79 | 77 | 80 | 78 | 77 | 78 | 76 | 77 | 75 | 71 |
| Sustainability and Equity Question 3 Score: Results lead to intervention/strategy that strengthens partnerships between private sector and government? | 83 | 78 | 77 | 68 | 74 | 82 | 80 | 76 | 75 | 71 | 74 | 72 | 72 | 73 | 70 |
| Sustainability and Equity Question 4 Score: Results lead to more equitable outcomes? | 75 | 71 | 77 | 68 | 70 | 70 | 73 | 71 | 73 | 69 | 78 | 71 | 69 | 70 | 71 |
| Importance and Potential Impact Question 1 Score:Results fill an important knowledge gap? | 81 | 80 | 80 | 74 | 82 | 85 | 83 | 83 | 81 | 80 | 79 | 78 | 81 | 78 | 77 |
| Importance and Potential Impact Question 2 Score: Results inform future policy and practice? | 84 | 83 | 83 | 78 | 79 | 83 | 81 | 82 | 82 | 79 | 82 | 78 | 81 | 78 | 78 |
| Importance and Potential Impact Question 3 Score: Results relevant to at least one aspect of private sector across range of low- and middle-income countries? | 83 | 83 | 82 | 81 | 78 | 84 | 80 | 82 | 81 | 80 | 80 | 80 | 81 | 79 | 78 |
| Importance and Potential Impact Question 4 Score: Will the results from the research help to strengthen quality of care provided by private health providers | 85 | 87 | 81 | 86 | 84 | 73 | 80 | 80 | 82 | 84 | 80 | 80 | 82 | 80 | 77 |
| Research Priority Score (Interquartile Range) | 82.1 (80.8-85.0) | 81.5 (78.8-85.1) | 80.3 (77.8-81.7) | 79.6 (74.3-85.4) | 79.3 (78.2-82.1) | 79.3 (73.9-83.3) | 79.0 (77.1-81.2) | 78.9 (76.1-81.7) | 78.8 (75.0-81.7) | 78.6 (76.7-82.5) | 78.2 (77.9-80.0) | 78.0 (75.7-80.4) | 77.3 (75.3-81.3) | 77.1 (75.4-79.2) | 76.5 (70.8-78.4) |
| Average Expert Agreement | 52 | 47 | 40 | 51 | 48 | 47 | 43 | 49 | 53 | 48 | 43 | 51 | 47 | 47 | 42 |
IMCI – integrated management of childhood illness, iCCM − integrated community case management
Rank, evaluation criteria scores, research priority scores, and average expert agreement for top ten questions in high income countries with complete surveys only (n = 18-33; varies by question)
| Rank | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research question | Does accreditation or regulation of private clinical and non-clinical sources of care improve IMCI diagnosis, treatment, and appropriateness of testing and prescription? | Can tools (eg,flipchart, decision tree, and other job aids) used by private providers/pharmacies/drug shops improve adherence to child health protocols (diarrhea and pneumonia management, malaria treatment, and nutritional screening and counseling? | Can government medicine regulatory authorities improve the quality of antimalarial medicines and antibiotics distributed by private drug shops or their equivalent through the use of periodic audits with a portable device to assess drug quality? | Can the iCCM approach be used in private non-clinical sources of care at scale to provide quality, appropriate, affordable, and accessible care? | What are the referral pathways in the private sector and what factors contribute to appropriate referrals to or from private sector providers? | What is the effect of social franchising with iCCM on access to child health care and outcomes? | |||||
| Answerability Question 1 Score: Single studies or small number of studies? | 76 | 79 | 78 | 79 | 76 | 75 | 69 | 73 | 70 | 77 | |
| Answerability Question 2 Score: Measurable outcome indicators? | 86 | 87 | 85 | 86 | 84 | 81 | 78 | 76 | 77 | 82 | |
| Research Feasibility Priority Score: Feasible to design and conduct study? | 80 | 86 | 79 | 83 | 83 | 82 | 78 | 78 | 75 | 80 | |
| Sustainability and Equity Question 1 Score: Results in sustainable intervention/ strategy to implement within context of private sector? | 85 | 84 | 79 | 79 | 79 | 80 | 77 | 78 | 79 | 78 | |
| Sustainability and Equity Question 2 Score: Results in scalable intervention/ strategy to implement within context of private sector? | 86 | 84 | 76 | 78 | 73 | 77 | 78 | 76 | 79 | 74 | |
| Sustainability and Equity Question 3 Score: Results lead to intervention/strategy that strengthens partnerships between private sector and government? | 83 | 66 | 75 | 72 | 73 | 70 | 75 | 79 | 72 | 68 | |
| Sustainability and Equity Question 4 Score: Results lead to more equitable outcomes? | 73 | 66 | 77 | 71 | 68 | 69 | 79 | 71 | 76 | 66 | |
| Importance and Potential Impact Question 1 Score:Results fill an important knowledge gap? | 82 | 74 | 81 | 79 | 77 | 81 | 79 | 82 | 80 | 77 | |
| Importance and Potential Impact Question 2 Score: Results inform future policy and practice? | 84 | 78 | 82 | 79 | 81 | 78 | 81 | 79 | 79 | 77 | |
| Importance and Potential Impact Question 3 Score: Results relevant to at least one aspect of private sector across range of low- and middle-income countries? | 83 | 81 | 81 | 80 | 78 | 76 | 79 | 78 | 77 | 79 | |
| Importance and Potential Impact Question 4 Score: Will the results from the research help to strengthen quality of care provided by private health providers | 85 | 88 | 80 | 82 | 85 | 85 | 79 | 78 | 75 | 83 | |
| Research Priority Score (interquartile range) | 82.1 (80.0-85.0) | 79.4 (74.2-85.6) | 79.4 (76.7-81.3) | 79.0 (78.1-81.9) | 77.9 (73.1-82.6) | 77.8 (74.8-81.3) | 77.5 (76.9-79.4) | 77.1 (75.8-78.8) | 76.5 (75.3-79.4) | 76.5 (74.4-80.0) | |
| Average Expert Agreement | 55 | 53 | 41 | 50 | 46 | 50 | 43 | 41 | 47 | 47 | |
IMCI – integrated management of childhood illness, iCCM – integrated community case management
Rank, evaluation criteria scores, research priority scores, and average expert agreement for top ten questions in low-and middle income countries with complete surveys only (n = 11-16; varies by question)
| Rank | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Research question | How can the integration of routine child health data from private sector providers (clinical and non-clinical) into national health information systems be improved and sustained? | What models of supportive supervision for child health service delivery are most cost-effective in the private sector? | What interventions are most effective in closing the gap between private provider knowledge and implementation of IMCI protocols? | What can be done to reduce over-prescription of antibiotics when malaria rapid diagnostic testing results are negative and there are no other indications for antibiotic use? | What are the referral pathways in the private sector and what factors contribute to appropriate referrals to or from private sector providers? | How well do private sector providers adhere to IMCI protocols? | |||||
| Answerability Question 1 Score: Single studies or small number of studies? | 91 | 83 | 81 | 83 | 83 | 85 | 83 | 86 | 88 | 83 | |
| Answerability Question 2 Score: Measurable outcome indicators? | 90 | 85 | 85 | 85 | 80 | 85 | 81 | 84 | 88 | 88 | |
| Research Feasibility Priority Score: Feasible to design and conduct study? | 90 | 86 | 83 | 86 | 84 | 88 | 88 | 88 | 89 | 85 | |
| Sustainability and Equity Question 1 Score: Results in sustainable intervention/ strategy to implement within context of private sector? | 90 | 88 | 88 | 87 | 83 | 84 | 80 | 83 | 78 | 84 | |
| Sustainability and Equity Question 2 Score: Results in scalable intervention/ strategy to implement within context of private sector? | 90 | 86 | 86 | 86 | 84 | 81 | 80 | 83 | 75 | 81 | |
| Sustainability and Equity Question 3 Score: Results lead to intervention/strategy that strengthens partnerships between private sector and government? | 89 | 89 | 87 | 81 | 79 | 75 | 84 | 81 | 76 | 80 | |
| Sustainability and Equity Question 4 Score: Results lead to more equitable outcomes? | 76 | 76 | 76 | 75 | 76 | 74 | 76 | 72 | 76 | 78 | |
| Importance and Potential Impact Question 1 Score: Results fill an important knowledge gap? | 88 | 89 | 85 | 83 | 88 | 85 | 85 | 83 | 83 | 76 | |
| Importance and Potential Impact Question 2 Score: Results inform future policy and practice? | 88 | 89 | 86 | 85 | 85 | 84 | 85 | 81 | 85 | 84 | |
| Importance and Potential Impact Question 3 Score: Results relevant to at least one aspect of private sector across range of low- and middle-income countries? | 91 | 90 | 81 | 85 | 88 | 84 | 84 | 83 | 84 | 84 | |
| Importance and Potential Impact Question 4 Score: Will the results from the research help to strengthen quality of care provided by private health providers | 90 | 80 | 85 | 85 | 86 | 88 | 85 | 83 | 84 | 83 | |
| Research Priority Score (interquartile range) | 88.5 (88.0-90.0) | 85.5 (82.5-88.8) | 83.9 (81.3-86.3) | 83.7 (82.5-86.3) | 83.2 (80.0-85.7) | 82.9 (81.3-85.3) | 82.7 (80.0-85.0) | 82.4 (81.4-83.8) | 82.2 (76.3-87.5) | 82.2 (80.0-83.8) | |
| Average Expert Agreement | 54 | 51 | 52 | 52 | 45 | 53 | 50 | 44 | 45 | 43 | |
IMCI – Integrated management of childhood illness